Compare SOPH & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOPH | SDHY |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.1M | 398.0M |
| IPO Year | 2021 | N/A |
| Metric | SOPH | SDHY |
|---|---|---|
| Price | $4.98 | $15.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 88.5K | 76.9K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | N/A |
| Revenue This Year | $23.09 | N/A |
| Revenue Next Year | $19.57 | N/A |
| P/E Ratio | ★ N/A | $14.96 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.59 | $15.55 |
| 52 Week High | $5.70 | $17.18 |
| Indicator | SOPH | SDHY |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 44.36 |
| Support Level | $4.54 | $15.76 |
| Resistance Level | $5.29 | $16.25 |
| Average True Range (ATR) | 0.28 | 0.15 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 71.64 | 40.45 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It mainly invests in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments (including derivatives) with similar economic characteristics.